Preliminary experience with sofosbuvir-based treatment regimens for patients dependent on hemodialysis

  • Rajiv Mehta
  • Ketan Desai
  • Mayank Kabrawala
  • Subhash Nandwani
  • Jatin Shah
  • Nisha Desai
  • Viral Parekh
LETTER

References

  1. 1.
    Bhamidimarri KR, Martin P. Finally, safe and effective treatment options for hepatitis C in hemodialysis patients. J Hepatol. 2016;65:7–10.Google Scholar
  2. 2.
    Pockros PJ, Reddy KR, Mantry PS, et al. Efficacy of direct-acting antiviral combination for patients with hepatitis C virus genotype 1 infection and severe renal impairment or end-stage renal disease. Gastroenterology. 2016;150:1590–8.Google Scholar
  3. 3.
    Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007;14:697–703.PubMedGoogle Scholar
  4. 4.
    Lee JJ, Lin MY, Chang JS, et al. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis. PLoS One. 2014;9:e100790.Google Scholar
  5. 5.
    Satapathy SK, Lingisetty CS, Williams S. Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection. Hepatol Int. 2012;6:369–78.Google Scholar
  6. 6.
    Kwon E, Cho JH, Jang HM, et al. Differential effect of viral hepatitis infection on mortality among Korean maintenance dialysis patients: a prospective multicenter cohort study. PLoS One. 2015;10:e0135476.Google Scholar
  7. 7.
    Choudhary NS, Kumar A, Bodh V, et al. Efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C patients on dialysis. Indian J Gastroenterol. 2017;36:113–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Akhil MS, Kirushnan B, Martin M, Arumugam K, Ganesh Prasad NK, Ravichandran R. Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: a retrospective study. Nephrology (Carlton). 2017;  https://doi.org/10.1111/nep.13050.
  9. 9.
    Saxena V, Koraishy FM, Sise ME, et al. Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function. Liver Int. 2016;36:807–16.Google Scholar
  10. 10.
    Desnoyer A, Pospai D, Le MP, et al. Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C. J Hepatol. 2016;65:40–7.CrossRefPubMedGoogle Scholar

Copyright information

© Indian Society of Gastroenterology 2018

Authors and Affiliations

  • Rajiv Mehta
    • 1
  • Ketan Desai
    • 2
  • Mayank Kabrawala
    • 1
  • Subhash Nandwani
    • 1
  • Jatin Shah
    • 1
  • Nisha Desai
    • 2
  • Viral Parekh
    • 1
  1. 1.Department of GastroenterologySurat Institute of Digestive SciencesSuratIndia
  2. 2.Department of NephrologySmt RB Shah Mahavir Superspeciality HospitalSuratIndia

Personalised recommendations